Literature DB >> 18799806

N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk.

Lipeng Wang1, Markos Leggas, Mamta Goswami, Philip E Empey, Patrick J McNamara.   

Abstract

Genetic knockout mice studies suggested ATP-binding cassette transporter family G member 2 (ABCG2)/Abcg2 translocates nitrofurantoin at the mammary-blood barrier, resulting in drug accumulation in milk. The purpose of this study was to establish the role of Abcg2 in nitrofurantoin accumulation in rat milk using N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a "chemical knockout" equivalent. The inhibitory effect of GF120918 was verified in Madin-Darby canine kidney II cells stably expressing rat Abcg2 with Hoechst 33342 and nitrofurantoin flux in Transwells. Nitrofurantoin was infused (0.5 mg/h) in the absence and presence of GF120918 (10 mg/kg in dimethyl sulfoxide) to Sprague-Dawley lactating female rats using a balanced crossover design. Administration of GF120918 increased nitrofurantoin concentration in serum (from 443 +/- 51 to 650 +/- 120 ng/ml) and decreased concentration in milk (from 18.1 +/- 0.9 to 1.9 +/- 1.2 microg/ml), resulting in corresponding mean values for milk to serum concentration ratio (M/S) of 41.4 +/- 19.1 versus 3.04 +/- 2.27 in the absence and presence of GF120918 (p < 0.05), respectively. There was a decrease in systemic clearance with GF120918 (2.8 +/- 0.5 l/h/kg) compared with vehicle controls (4.1 +/- 0.5 l/h/kg; p < 0.05). Western blot analysis revealed good expression of Abcg2 and no P-glycoprotein (P-gp) expression in mammary gland, whereas immunohistochemistry confirmed the apical expression of Abcg2 in lactating mammary gland epithelia. Nitrofurantoin active transport into rat milk can be inhibited by GF120918 resulting in a 10-fold lower M/S. Although GF120918 inhibits both Abcg2 and P-gp, the high expression of Abcg2 and the absence of detectable P-gp expression in lactating mammary gland validate an important role for Abcg2 in nitrofurantoin accumulation in rat milk. GF120918 is particularly useful as a rat chemical knockout model to establish ABCG2's role in drug transfer into milk during breastfeeding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799806      PMCID: PMC2837273          DOI: 10.1124/dmd.108.021980

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  35 in total

1.  Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction.

Authors:  J Alcorn; X Lu; J A Moscow; P J McNamara
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

2.  MDR1 modulators improve the chemotherapy response of human hepatoblastoma to doxorubicin in vitro.

Authors:  Steven Warmann; Gudrun Göhring; Birgit Teichmann; Heinz Geerlings; Jörg Fuchs
Journal:  J Pediatr Surg       Date:  2002-11       Impact factor: 2.545

3.  Active transport of nitrofurantoin into human milk.

Authors:  P M Gerk; R J Kuhn; N S Desai; P J McNamara
Journal:  Pharmacotherapy       Date:  2001-06       Impact factor: 4.705

4.  Active transport of nitrofurantoin into rat milk.

Authors:  C Y Oo; E W Paxton; P J McNamara
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

Review 5.  Multidrug resistance transporters and modulation.

Authors:  B Tan; D Piwnica-Worms; L Ratner
Journal:  Curr Opin Oncol       Date:  2000-09       Impact factor: 3.645

6.  Sodium dependence of nitrofurantoin active transport across mammary epithelia and effects of dipyridamole, nucleosides, and nucleobases.

Authors:  Phillip M Gerk; Linda Hanson; Margaret C Neville; Patrick J McNamara
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

7.  Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2.

Authors:  Thomas Litman; Ulla Jensen; Alastair Hansen; Kuang-Ming Covitz; Zhirong Zhan; Patricia Fetsch; Andrea Abati; Paul Robert Hansen; Thomas Horn; Torben Skovsgaard; Susan E Bates
Journal:  Biochim Biophys Acta       Date:  2002-09-20

8.  HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Anshul Gupta; Yi Zhang; Jashvant D Unadkat; Qingcheng Mao
Journal:  J Pharmacol Exp Ther       Date:  2004-03-08       Impact factor: 4.030

9.  Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells.

Authors:  Poulomi Acharya; Michael P O'Connor; Joseph W Polli; Andrew Ayrton; Harma Ellens; Joe Bentz
Journal:  Drug Metab Dispos       Date:  2007-10-29       Impact factor: 3.922

10.  Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.

Authors:  Salvatore Cisternino; Claire Mercier; Fanchon Bourasset; Françoise Roux; Jean-Michel Scherrmann
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

View more
  7 in total

1.  Quantifying mitochondrial and plasma membrane potentials in intact pulmonary arterial endothelial cells based on extracellular disposition of rhodamine dyes.

Authors:  Zhuohui Gan; Said H Audi; Robert D Bongard; Kathryn M Gauthier; Marilyn P Merker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

2.  The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP.

Authors:  Borja Barrera; Jon A Otero; Estefanía Egido; Julio G Prieto; Anna Seelig; Ana I Álvarez; Gracia Merino
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

3.  In vivo inhibition of BCRP/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (-/-) mice.

Authors:  Gracia Merino; Miriam Perez; Rebeca Real; Estefania Egido; Julio G Prieto; Ana I Alvarez
Journal:  Pharm Res       Date:  2010-07-07       Impact factor: 4.200

Review 4.  What do drug transporters really do?

Authors:  Sanjay K Nigam
Journal:  Nat Rev Drug Discov       Date:  2014-12-05       Impact factor: 84.694

5.  Stereoselective interaction of pantoprazole with ABCG2. II. In vitro flux analysis.

Authors:  Lipeng Wang; Markos Leggas; Philip E Empey; Patrick J McNamara
Journal:  Drug Metab Dispos       Date:  2012-02-21       Impact factor: 3.922

Review 6.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

Review 7.  Transporters in the Mammary Gland-Contribution to Presence of Nutrients and Drugs into Milk.

Authors:  Alba M García-Lino; Indira Álvarez-Fernández; Esther Blanco-Paniagua; Gracia Merino; Ana I Álvarez
Journal:  Nutrients       Date:  2019-10-05       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.